Complete Genome Sequence of Linezolid-Susceptible Staphylococcus haemolyticus Sh29/312/L2, a Clonal Derivative of a Linezolid-Resistant Clinical Strain

Lara M de Almeida; Carlos Pires; Louise T Cerdeira; Théo G M de Oliveira; John Anthony McCulloch; Paula Juliana Perez-Chaparro; Andrey G Sacramento; Artemir C Brito; Joás L da Silva; Maria Rita E de Araújo; Nilton Lincopan; Melissa J Martin; Michael S Gilmore; Elsa M Mamizuka

doi:10.1128/genomeA.00494-15

Complete Genome Sequence of Linezolid-Susceptible Staphylococcus haemolyticus Sh29/312/L2, a Clonal Derivative of a Linezolid-Resistant Clinical Strain

Genome Announc. 2015 May 21;3(3):e00494-15. doi: 10.1128/genomeA.00494-15.

Affiliations

¹ Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil larameal@gmail.com.
² Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
³ Centro de facilidades de apoio a pesquisa CEFAP, University of São Paulo, São Paulo, Brazil.
⁴ Laboratory of Genetic and Molecular Cardiology, Heart Institute, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
⁵ Faculty of Pharmaceutical Sciences, São Paulo State University, Araraquara, Brazil.
⁶ Hospital Beneficência, Portuguesa, São Paulo, Brazil.
⁷ Departments of Ophthalmology, Microbiology and Immunobiology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Abstract

We report the whole-genome sequence (WGS) of an in vitro susceptible derivative revertant mutant from a bloodstream isolate involved in a nosocomial outbreak in Brazil. The WGS comprises 2.5 Mb with 2,500 protein-coding sequences, 16rRNA genes, and 60 tRNA genes.

Grants and funding

P30 EY014104/EY/NEI NIH HHS/United States